BioRem Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was CAD 12.21 million compared to CAD 10.91 million a year ago. Net income was CAD 2.36 million compared to CAD 0.789 million a year ago.

Basic earnings per share from continuing operations was CAD 0.15 compared to CAD 0.05 a year ago. Diluted earnings per share from continuing operations was CAD 0.14 compared to CAD 0.05 a year ago.